Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

12.55
Delayed Data
As of Mar 23
 -0.25 / -1.95%
Today’s Change
6.27
Today|||52-Week Range
13.70
+3.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues30.6M46.9M28.7M106.4M
 
 
 
 
 
Depreciation And Amortization433.0K490.0K589.0K741.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses64.1M61.2M65.5M91.5M
 
 
 
 
 
Research And Development49.5M44.4M46.4M64.4M
 
 
 
 
 
Total Operating Expenses64.5M61.7M66.1M92.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.9M-14.8M-37.4M14.2M
 
 
 
 
 
Extraordinary Credit0.000.000.004.5M
 
 
Interest Expense On Debt--0.00250.0K2.7M
 
 
 
Other Expenses79.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-33.7M-14.6M-37.5M16.5M
 
 
 
 
 
Net Income-33.7M-14.6M-37.5M16.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.3M35.7M38.8M39.9M
 
 
 
 
 
Shares To Calculate EPS Diluted27.3M35.7M38.8M42.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.24-$0.41-$0.97$0.39
 
 
 
 
 
EPS Diluted-$1.24-$0.41-$0.97$0.39